CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CANbridge Pharmaceuticals Inc. has announced its board composition, including Executive Director Dr. James Qun Xue as Chairman and CEO, alongside a list of Non-executive and Independent Non-executive Directors. The company’s board includes three key committees: Audit, Remuneration, and Nomination and Corporate Governance, with various members serving as chairpersons and committee members.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.